Three prototype vaccine Vector from COVID-19 has shown its efficiency, — RIA “news” told the Director of the center “Vector” Rinat Maksyutov.
— This is the most advanced from the point of view of the obtained results drugs. The most important is protection from disease in those vaccinated. To create a safe drug capable of forming this protection is the biggest challenge, said native. In the development of vaccines involved more than 100 employees.
Rinat Maksyutov also explained that to assess the immunogenicity of the Vector realizing the importance of effective drug tests the vaccine on four types of animals: mice, Guinea pigs, rabbits, and primates.
